IL-6 regulates adipose deposition and homeostasis in lymphedema

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 306, Issue 10, 2014, Pages

  Cuzzone, Daniel A ^a   Weitman, Evan S ^a   Albano, Nicholas J ^a   Ghanta, Swapna ^a   Savetsky, Ira L ^a   Gardenier, Jason C ^a   Joseph, Walter J ^a   Torrisi, Jeremy S ^a   Bromberg, Jacqueline F ^a   Olszewski, Waldemar L ^b   Rockson, Stanley G ^c   Mehrara, Babak J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^c STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adipose; IL 6; Inflammation; Lymphedema; Serum levels

Indexed keywords

INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; EXCISION; FEMALE; HOMEOSTASIS; HUMAN; HUMAN TISSUE; INFLAMMATION; INJURY; LYMPHATIC EXCISION; LYMPHATIC INJURY; LYMPHEDEMA; MEDIATOR; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADIPOSE; IL-6; INFLAMMATION; LYMPHEDEMA; SERUM LEVELS;

ADIPOSE TISSUE; ADIPOSITY; ANIMALS; BIOPSY; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; FEMALE; HOMEOSTASIS; HUMANS; INTERLEUKIN-6; LYMPHEDEMA; LYMPHOID TISSUE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT;

EID: 84900550222     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01019.2013     Document Type: Article

References (38)

1. Akira D, Taga T, Kishimoto T. Interleukin-6 in biology and medicine. Adv Immunol 54: 1-78, 1993.
2. Aschen S, Zampell JC, Elhadad S, Weitman E, De Brot M, Mehrara BJ. Regulation of adipogenesis by lymphatic fluid stasis: part II expression of adipose differentiation genes. Plast Reconstr Surg 129: 838-847, 2012.
3. Avraham T, Clavin NW, Daluvoy SV, Fernandez J, Soares MA, Cordeiro AP, Mehrara BJ. Fibrosis is a key inhibitor of lymphatic regeneration. Plast Reconstr Surg 124: 438-450, 2009.
4. Avraham T, Daluvoy S, Zampell J, Yan A, Haviv YS, Rockson SG, Mehrara BJ. Blockade Of transforming growth factor-α1 accelerates lymphatic regeneration during wound repair. Am J Pathol 177: 3202-3214, 2010.
5. Avraham T, Zampell JC, Yan A, Elhadad S, Weitman ES, Rockson SG, Bromberg J, Mehrara BJ. Th2 differentiation is necessary for soft tissue fibrosis and lymphatic dysfunction resulting from lymphedema. FASEB J 27: 1114-1126, 2013.
6. Bastard JP, Jardel C, Bruckert E, Blondy P, Capeau J, Laville M, Vidal H, Hainque B. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 85: 3338-3342, 2000.
7. Bastard JP, Maachi M, Lagathu C, Kim Mj, Caron M, Vidal H, Capeau J, Feve B. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 17: 4-12, 2006.
8. Cinti S, Mitchell G, Barbatelli G, Murano I, Ceresi E, Faloia E, Wang S, Fortier M, Greenberg AS, Obin MS. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 46: 2347-2355, 2005.
9. Clavin NW, Avraham T, Fernandez J, Daluvoy SV, Soares MA, Chaudhry A, Mehrara BJ. TGF-β1 is a negative regulator of lymphatic regeneration during wound repair. Am J Physiol Heart Circ Physiol 295: H2113-H2127, 2008.
10. De Ferranti S, Mozaffarian D. The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem 54: 945-955, 2008.
11. Franckhauser S, Elias I, Rotter Sopasakis V, Ferre T, Nagaev I, Andersson CX, Agudo J, Ruberte J, Bosch F, Smith U. Overexpression of IL-6 leads to hyperinsulinaemia, liver inflammation and reduced body weight in mice. Diabetologia 51: 1306-1316, 2008.
12. Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 83: 847-850, 1998.
13. Gil A, Maria Aguilera C, Gil-Campos M, Canete R. Altered signalling and gene expression associated with the immune system and the inflammatory response in obesity. Br J Nutr 98, Suppl 1: s121-s126, 2007.
14. Halberg N, Khan T, Trujillo ME, Wernstedt-Asterholm I, Attie AD, Sherwani S, Wang ZV, Landskroner-Eiger S, Dineen S, Magalang UJ, Brekken RA, Scherer PE. Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue. Mol Cell Biol 29: 4467-4483, 2009.
15. Harvey NL, Srinivasan RS, Dillard ME, Johnson NC, Witte MH, Boyd K, Sleeman MW, Oliver G. Lymphatic vascular defects promoted by prox1 haploinsufficiency cause adult-onset obesity. Nat Genet 37: 1072-1081, 2005.
16. International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2013 consensus document of the international society of lymphology. Lymphology 46: 1-11, 2013.
17. Ji C, Chen X, Gao C, Jiao L, Wang J, Xu G, Fu H, Guo X, Zhao Y. IL-6 induces lipolysis and mitochondrial dysfunction, but does not affect insulin-mediated glucose transport in 3t3-l1 adipocytes. J Bioenerg Biomembr 43: 367-375, 2011.
18. Karlsen TV, Karkkainen MJ, Alitalo K, Wiig H. Transcapillary fluid balance consequences of missing initial lymphatics studied in a mouse model of primary lymphoedema. J Physiol 574: 583-596, 2006.
19. Lé ka, Mahurkar S, Alderete TL, Hasson RE, Adam TC, Kim JS, Beale E, Xie C, Greenberg AS, Allayee H, Goran MI. Subcutaneous adipose tissue macrophage infiltration is associated with hepatic and visceral fat deposition, hyperinsulinemia, and stimulation of NF-kappaB stress pathway. Diabetes 60: 2802-2809, 2011.
20. Lyngso D, Simonsen L, Bulow J. Interleukin-6 production in human subcutaneous abdominal adipose tissue: the effect of exercise. J Physiol 543: 373-378, 2002.
21. Lyngso D, Simonsen L, Bulow J. Metabolic effects of interleukin-6 in human splanchnic and adipose tissue. J Physiol 543: 379-386, 2002.
22. Mehrara BJ, Avraham T, Soares M, Fernandez JG, Yan A, Zampell JC, Andrade VP, Cordeiro AP, Sorrento CM. P21cip/WAF is a key regulator of long-term radiation damage in mesenchyme-derived tissues. FASEB J 24: 4877-4888, 2010.
23. Mei M, Zhao L, Li Q, Chen Y, Huang A, Varghese Z, Moorhead JF, Zhang S, Powis SH, Li Q, Ruan XZ. Inflammatory stress exacerbates ectopic lipid deposition in C57BL/6J mice. Lipids Health Dis 10: 110, 2011.
24. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S, Coppack SW. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 82: 4196-4200, 1997.
25. Neurath MF, Finotto S. IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer. Cytokine Growth Factor Rev 22: 83-89, 2011.
26. Olszewski WL, Jamal S, Lukomska B, Manokaran G, Grzelak I. Immune proteins in peripheral tissue fluid-lymph in patients with filarial lymphedema of the lower limbs. Lymphology 25: 166-171, 1992.
27. Petersen EW, Carey AL, Sacchetti M, Steinberg GR, Macaulay SL, Febbraio MA, Pedersen BK. Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro. Am J Physiol Endocrinol Metab 288: E155-E162, 2005.
28. Roytblat L, Rachinsky M, Fisher A, Greemberg L, Shapira Y, Douvdevani A, Gelman S. Raised interleukin-6 levels in obese patients. Obes Res 8: 673-675, 2000.
29. Rutkowski JM, Davis KE, Scherer PE. Mechanisms of obesity and related pathologies: the macro-and microcirculation of adipose tissue. FEBS J 276: 5738-5746, 2009.
30. Rutkowski JM, Moya M, Johannes J, Goldman J, Swartz MA. Secondary lymphedema in the mouse tail: lymphatic hyperplasia, VEGF-c upregulation, and the protective role of MMP-9. Microvasc Res 72: 161-171, 2006.
31. Tabibiazar R, Cheung L, Han J, Swanson J, Beilhack A, An A, Dadras SS, Rockson N, Joshi S, Wagner R, Rockson SG. Inflammatory manifestations of experimental lymphatic insufficiency. PLos Med 3: e254, 2006.
32. Van Hall G, Steensberg A, Sacchetti M, Fischer C, Keller C, Schjerling P, Hiscock N, Moller K, Saltin B, Febbraio MA, Pedersen BK. Interleukin-6 stimulates lipolysis and fat oxidation in humans. J Clin Endocrinol Metab 88: 3005-3010, 2003.
33. Wallenius V, Wallenius K, Ahren B, Rudling M, Carlsten H, Dickson SL, Ohlsson C, Jansson JO. Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 8: 75-79, 2002.
34. Wolsk E, Mygind H, Grondahl TS, Pedersen BK, Van Hall G. IL-6 selectively stimulates fat metabolism in human skeletal muscle. Am J Physiol Endocrinol Metab 299: E832-E840, 2010.
35. Ye J. Emerging role of adipose tissue hypoxia in obesity and insulin resistance. Int J Obes (Lond) 33: 54-66, 2009.
36. Zaleska M, Olszewski WL, Durlik M, Miller NE. Signaling proteins are represented in tissue fluid/lymph from soft tissues of normal human legs at concentrations different from serum. Lymphat Res Biol 11: 203-210, 2013.
37. Zampell JC, Yan A, Avraham T, Andrade V, Malliaris S, Aschen S, Rockson SG, Mehrara BJ. Temporal and spatial patterns of endogenous danger signal expression after wound healing and in response to lymphedema. Am J Physiol Cell Physiol 300: C1107-C1121, 2011.
38. + cells regulate fibrosis and lymphangiogenesis in response to lymphatic fluid stasis. PLos One 7: e49940, 2012.